Literature DB >> 15359634

More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians.

Guillermo J Ruiz-Argüelles1, Javier Garcés-Eisele, Virginia Reyes-Núñez, José David Gómez-Rangel, Guillermo J Ruiz-Delgado.   

Abstract

Acute promyelocytic leukemia is characterized the PML/RARalpha chimeric fusion gene, transcript and protein; the breakpoint cluster regions (bcr) in the PML gene may occur in 3 different sites: Intron 6 (bcr1), exon 6 (bcr2) or intron 3 (bcr3). In a 10-year period in a single institution, we studied prospectively the breakpoint cluster regions of the PML/RARalpha fusion gene in 43 Mexican Mestizo patients with APL, and found that the bcr1 represented 62.7%, the bcr2 9.3% whereas the bcr3 27.9%. The prevalence of the bcr1 subtype is significantly higher than that informed in Caucasians and similar to that in Asians; these data are consonant with those described in other Latin-American patients with APL. Since other Asian genetic markers have been found in the Indian component of the Mexican mestizos, it is possible that the Asian immigration into the Americas through the strait of Behring 12,000 years ago may account for a possible genetic susceptibility to suffer certain forms of APL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359634     DOI: 10.1080/10428190310001657344

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  On the prevalence and genetic predisposition of monoclonal gammopathy of undetermined significance (MGUS).

Authors:  Guillermo J Ruiz-Argüelles; Guillermo J Ruiz-Delgado
Journal:  Int J Hematol       Date:  2012-06-03       Impact factor: 2.490

2.  Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Authors:  Graça M Dores; Susan S Devesa; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

3.  [Clinical and genetic characteristics of patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective of 790 cases].

Authors:  M Z Yang; L Li; H Wei; B C Liu; K Q Liu; D P Li; L Zhang; R C Yang; Y C Mi; J X Wang; Y Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-04-14

4.  Epidemiology and treatment of acute promyelocytic leukemia in latin america.

Authors:  E M Rego; R H Jácomo
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

5.  Pediatric Acute Promyelocytic Leukemia: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome.

Authors:  Francianne G Andrade; Suellen V M Feliciano; Ingrid Sardou-Cezar; Gisele D Brisson; Filipe V Dos Santos-Bueno; Danielle T Vianna; Luísa V C Marques; Eugênia Terra-Granado; Ilana Zalcberg; Marceli de O Santos; Juliana T Costa; Elda P Noronha; Luiz C S Thuler; Joseph L Wiemels; Maria S Pombo-de-Oliveira
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

Review 6.  Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy.

Authors:  Viera Dobrotkova; Petr Chlapek; Pavel Mazanek; Jaroslav Sterba; Renata Veselska
Journal:  BMC Cancer       Date:  2018-11-01       Impact factor: 4.430

Review 7.  Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.

Authors:  Luis Antonio Meillon-Garcia; Roberta Demichelis-Gómez
Journal:  Curr Oncol Rep       Date:  2020-10-06       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.